Keith Devas
Stock Analyst at Jefferies
(0.57)
# 3,941
Out of 4,396 analysts
27
Total ratings
21.4%
Success rate
-11.4%
Average return
Main Sectors:
Stocks Rated by Keith Devas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Reiterated: Buy | $785 → $792 | $578.89 | +36.81% | 4 | May 6, 2026 | |
| PBH Prestige Consumer Healthcare | Maintained: Hold | $71 → $66 | $48.66 | +35.64% | 4 | Jan 30, 2026 | |
| KVUE Kenvue | Downgraded: Hold | $23 → $18 | $17.92 | +0.45% | 15 | Jan 30, 2026 | |
| PRGO Perrigo Company | Maintained: Hold | $27 → $23 | $11.18 | +105.72% | 4 | Oct 27, 2025 |
IDEXX Laboratories
May 6, 2026
Reiterated: Buy
Price Target: $785 → $792
Current: $578.89
Upside: +36.81%
Prestige Consumer Healthcare
Jan 30, 2026
Maintained: Hold
Price Target: $71 → $66
Current: $48.66
Upside: +35.64%
Kenvue
Jan 30, 2026
Downgraded: Hold
Price Target: $23 → $18
Current: $17.92
Upside: +0.45%
Perrigo Company
Oct 27, 2025
Maintained: Hold
Price Target: $27 → $23
Current: $11.18
Upside: +105.72%